Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Back to Search Results

Dr Lee Jie Xin Joycelyn

MBBS, MRCP (UK), M Med (Internal Medicine)

Consultant

Specialty: Medical Oncology

Sub-specialties: Upper Gastrointestinal

Conditions Treated by this Doctor:
Upper Gastrointestinal Cancers.

Clinical Appointments

Consultant Division of Medical Oncology National Cancer Centre Singapore

Academic Appointments

Adjunct Instructor

Profile

Dr Joycelyn Lee is a Consultant in the Division of Medical Oncology at National Cancer Centre Singapore. Her interest is in Gastrointestinal cancers.

Education

MRCP (UK) 2013
MMed Int Med (S’pore) 2013
MBBS (S’pore) 2011

Professional Appointments and Committee Memberships

Consultant, Division of Medical Oncology, National Cancer Centre Singapore - present
Associate Consultant, Division of Medical Oncology, National Cancer Centre Singapore 2017 - 2019

Awards

Young Educator Award 2012; Awarded by Singhealth Residency
1st Mekie Book Prize 2011; Awarded by Yong Loo Lin School of Medicine, NUS

Research Interests

Gastrointestinal cancers
Cancer Cachexia

Publications and Research Trials

A review of invasive lobular carcinoma of the breast: Should it be treated like invasive ductal carcinoma? Lee JJX, Lee GE. Integr Cancer Sci Therap 2016; 3(5); doi: 10.15761/ICST.1000211
Clinicopathological characteristics and treatment outcomes in patients with stage I-III invasive Lobular carcinoma of the breast (ILC) treated at the National Cancer Centre Singapore. JJX Lee, Wong FY, J Ngeow et al. J Clin Oncol 34, 2016 (suppl; abstr e12005)
Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor. JJX Lee, A Chan, T Tang. Acta Oncologica 2016; doi: 10.3109/0284186X.2015.1125017
Primary spinal oligoastrocytoma mimicking longitudinally extensive transverse myelitis. TR Yeo, CF Wong, JJX Lee, VZY Ng, K Tan. Multiple Sclerosis and Related Disorders 2015; 3: 590 – 593.
Clinical Development of c-MET inhibition in Hepatocellular Carcinoma. JJX Lee, JJ Chan, SP Choo. Diseases 2015; 3: 306 – 324.
PI3K/Akt/mTOR inhibitors in breast cancer. JJX Lee, K Loh, YS Yap. Cancer Biol Med 2015;12: 342 – 354.
One patient, two uncommon B-cell neoplasms: solitary plasmacytoma following complete remission from intravascular large B-cell lymphoma involving central nervous system. J Lee, SY Tan, LHC Tan, HY Lee, KL Chuah, T Tang, R Quek, K Tay, M Tao, ST Lim, M Farid. Case Reports in Medicine 2014; doi:10.1155/2014/620423 (Article ID 62042)

Research Trials

Repurposing Trimetazidine in Cancer Cachexia 2017 - ongoing

Tags: Medical Oncology, Upper Gastrointestinal, Upper Gastrointestinal Cancers
Updated on